Released Apr 16, 2012, after the close
10-K filed Apr 16, 2012, 107 days after period end · 0001437749-12-003901
Q4 2011 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$545.45K$545.45K derivedno prior Q4 2010 on file−5.0% vs Q3 2011
Net Income-$1.00M-$1.00M derivedno prior Q4 2010 on fileN/M vs Q3 2011
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$353,325—
Operating Incomederived-$970,591—
Operating Cash Flowderived-$150,081N/M
Free Cash Flowderived-$150,081N/M
Margins · derived
Gross margin64.8%
Operating margin-177.9%
Net margin-183.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $545.45K | — |
| Net Income | -$1.00M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR